Cancer

Cancer

Enzyme-Responsive Biomimetic Ferritin Nanoparticles for Selective Cancer Therapy

Researchers from the South China University of Technology have proposed a novel biomimetic nanoplatform for precise and selective cancer therapy. This innovative approach involves the use of enzyme-mediated activation of natural cytolytic peptides (NCPs) within tumor microenvironments, minimizing non-selective cytotoxicity and hemolysis. The biomimetic ferritin nanoparticles (MMFn) are designed to